Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro

Autor: Henie M. J. Roelofs, Wilbert H.M. Peters, Hilbert S. de Vries, Rene H. M. te Morsche, Dirk J. de Jong, Tineke de Heij

Publikováno v: Digestive Diseases and Sciences, 57, 6, pp. 1604-8
Digestive Diseases and Sciences, 57, 1604-8
Digestive Diseases and Sciences

Contains fulltext : 108348.pdf (Publisher’s version ) (Open Access) BACKGROUND: Infliximab-induced hepatotoxicity is reported in several case studies involving patients with inflammatory bowel disease (IBD) and a direct hepatotoxic effect has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e965b917f6ecd14bbe25beed084bb2a9
https://doi.org/10.1007/s10620-012-2159-7